Gary L. Crocker
2017
In 2017, Gary L. Crocker earned a total compensation of $175.3K as Chairman of the Board and former Interim President and Chief Executive Officer at Merrimack Pharmaceuticals, a 43% decrease compared to previous year.
Compensation breakdown
| Option Awards | $67,552 |
|---|---|
| Salary | $31,000 |
| Other | $76,722 |
| Total | $175,274 |
Crocker received $76.7K in other compensation, accounting for 44% of the total pay in 2017.
Crocker also received $67.6K in option awards and $31K in salary.
Rankings
In 2017, Gary L. Crocker's compensation ranked 14,162nd out of 14,666 executives tracked by ExecPay. In other words, Crocker earned more than 3.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 14,162 out of 14,666 | 3rd |
Division Manufacturing | 5,564 out of 5,772 | 4th |
Major group Chemicals And Allied Products | 1,997 out of 2,075 | 4th |
Industry group Drugs | 1,664 out of 1,731 | 4th |
Industry Pharmaceutical Preparations | 1,277 out of 1,333 | 4th |
Source: SEC filing on April 27, 2018.
Crocker's colleagues
We found six more compensation records of executives who worked with Gary L. Crocker at Merrimack Pharmaceuticals in 2017.
2017
Richard Peters
Merrimack Pharmaceuticals
Chief Executive Officer
2017
Jeffrey Munsie
Merrimack Pharmaceuticals
General Counsel
2017
Daryl Drummond
Merrimack Pharmaceuticals
Head of Research
2017
Sergio Santillana
Merrimack Pharmaceuticals
Chief Medical Officer
2017
Jean Franchi
Merrimack Pharmaceuticals
Chief Financial Officer
2017
Yasir Al-Wakeel
Merrimack Pharmaceuticals